Identification of complement regulatory domains in human factor H.
Open Access
- 1 July 1995
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 155 (1) , 348-356
- https://doi.org/10.4049/jimmunol.155.1.348
Abstract
Factor H, a regulator of complement activation, contains 20 short consensus repeat (SCR) domains common among the family of C3b/C4b-binding proteins. Chinese hamster ovary cells transfected with cDNA corresponding to the N-terminal tryptic fragment of factor H (containing SCR 1-5 and part of SCR 6) secreted protein with cofactor activity for factor I-dependent cleavage of C3b. A series of deletion mutants, each lacking one of the first five SCR, were constructed, and the supernatants of transfected Chinese hamster ovary cells were tested for cofactor activity. Supernatants of Chinese hamster ovary cells transfected with SCR 1, SCR 4, and SCR 5 deletion mutants retained cofactor function, although the SCR 1 deletion had reduced cofactor activity. Deletion of SCR 2 or 3 totally abolished cofactor activity. Expression and functional analysis of SCR units 1-3, 2-3, and 2-4 demonstrated that the SCR 1-3 unit is sufficient for cofactor activity, but SCR 1-4 is required for full activity. For assays involving cell protection, a construct linking SCR 1-5 to the glycosyl-phosphatidylinositol anchor of decay-accelerating factor was prepared, and stable transfectants were obtained. These cells were protected against complement-mediated cytotoxicity, similarly to decay-accelerating factor- and membrane cofactor protein-transfected cells. These studies define the complement regulatory domains in factor H and suggest that the general complement functional unit for C3 convertase regulation involves three or four consecutive SCR units.This publication has 26 references indexed in Scilit:
- Characterization of the lymphocyte membrane receptor for factor H (β1H- globulin) with an antibody to anti-factor H idiotypeThe Journal of Experimental Medicine, 1982
- The binding of human complement proteins C5, factor B, β1H and properdin to complement fragment C3b on zymosanBiochemical Journal, 1981
- Role of β1H for the binding of C3b‐coated particles to human lymphoid and phagocytic cellsEuropean Journal of Immunology, 1981
- HUMAN ALTERNATIVE COMPLEMENT PATHWAY - MEMBRANE-ASSOCIATED SIALIC-ACID REGULATES THE COMPETITION BETWEEN B AND BETA-1H FOR CELL-BOUND C3B1979
- Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cellsProceedings of the National Academy of Sciences, 1978
- Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathwayProceedings of the National Academy of Sciences, 1978
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Activation of the alternative complement pathway due to resistance of zymosan-bound.Proceedings of the National Academy of Sciences, 1977
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Control of the amplification convertase of complement by the plasma protein beta1H.Proceedings of the National Academy of Sciences, 1976